These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 28234556)

  • 1. Antiglycopeptide Mouse Monoclonal Antibody LpMab-21 Exerts Antitumor Activity Against Human Podoplanin Through Antibody-Dependent Cellular Cytotoxicity and Complement-Dependent Cytotoxicity.
    Kato Y; Kunita A; Fukayama M; Abe S; Nishioka Y; Uchida H; Tahara H; Yamada S; Yanaka M; Nakamura T; Saidoh N; Yoshida K; Fujii Y; Honma R; Takagi M; Ogasawara S; Murata T; Kaneko MK
    Monoclon Antib Immunodiagn Immunother; 2017 Feb; 36(1):20-24. PubMed ID: 28234556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ChLpMab-23: Cancer-Specific Human-Mouse Chimeric Anti-Podoplanin Antibody Exhibits Antitumor Activity via Antibody-Dependent Cellular Cytotoxicity.
    Kaneko MK; Nakamura T; Kunita A; Fukayama M; Abe S; Nishioka Y; Yamada S; Yanaka M; Saidoh N; Yoshida K; Fujii Y; Ogasawara S; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2017 Jun; 36(3):104-112. PubMed ID: 28504613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chimeric Anti-Human Podoplanin Antibody NZ-12 of Lambda Light Chain Exerts Higher Antibody-Dependent Cellular Cytotoxicity and Complement-Dependent Cytotoxicity Compared with NZ-8 of Kappa Light Chain.
    Kaneko MK; Abe S; Ogasawara S; Fujii Y; Yamada S; Murata T; Uchida H; Tahara H; Nishioka Y; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2017 Feb; 36(1):25-29. PubMed ID: 28157429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The chimeric antibody chLpMab-7 targeting human podoplanin suppresses pulmonary metastasis via ADCC and CDC rather than via its neutralizing activity.
    Kato Y; Kunita A; Abe S; Ogasawara S; Fujii Y; Oki H; Fukayama M; Nishioka Y; Kaneko MK
    Oncotarget; 2015 Nov; 6(34):36003-18. PubMed ID: 26416352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor activity of chLpMab-2, a human-mouse chimeric cancer-specific antihuman podoplanin antibody, via antibody-dependent cellular cytotoxicity.
    Kaneko MK; Yamada S; Nakamura T; Abe S; Nishioka Y; Kunita A; Fukayama M; Fujii Y; Ogasawara S; Kato Y
    Cancer Med; 2017 Apr; 6(4):768-777. PubMed ID: 28332312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of Core-Fucose-Deficient Humanized and Chimeric Anti-Human Podoplanin Antibodies.
    Kaneko MK; Ohishi T; Nakamura T; Inoue H; Takei J; Sano M; Asano T; Sayama Y; Hosono H; Suzuki H; Kawada M; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2020 Oct; 39(5):167-174. PubMed ID: 33085938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment of Mouse Monoclonal Antibody LpMab-13 Against Human Podoplanin.
    Ogasawara S; Kaneko MK; Honma R; Oki H; Fujii Y; Takagi M; Suzuki H; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2016 Jun; 35(3):155-62. PubMed ID: 27328060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal Antibody LpMab-9 Recognizes O-glycosylated N-Terminus of Human Podoplanin.
    Kaneko MK; Oki H; Hozumi Y; Liu X; Ogasawara S; Takagi M; Goto K; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2015 Oct; 34(5):310-7. PubMed ID: 26492618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Monoclonal Antibody LpMab-17 Developed by CasMab Technology Distinguishes Human Podoplanin from Monkey Podoplanin.
    Kato Y; Ogasawara S; Oki H; Honma R; Takagi M; Fujii Y; Nakamura T; Saidoh N; Kanno H; Umetsu M; Kamata S; Kubo H; Yamada M; Sawa Y; Morita K; Harada H; Suzuki H; Kaneko MK
    Monoclon Antib Immunodiagn Immunother; 2016 Apr; 35(2):109-16. PubMed ID: 26937552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and characterization of anti-glycopeptide monoclonal antibodies against human podoplanin, using glycan-deficient cell lines generated by CRISPR/Cas9 and TALEN.
    Kaneko MK; Nakamura T; Honma R; Ogasawara S; Fujii Y; Abe S; Takagi M; Harada H; Suzuki H; Nishioka Y; Kato Y
    Cancer Med; 2017 Feb; 6(2):382-396. PubMed ID: 28101903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment of P38Bf, a Core-Fucose-Deficient Mouse-Canine Chimeric Antibody Against Dog Podoplanin.
    Kato Y; Mizuno T; Yamada S; Nakamura T; Itai S; Yanaka M; Sano M; Kaneko MK
    Monoclon Antib Immunodiagn Immunother; 2018 Nov; 37(5):218-223. PubMed ID: 30362926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LpMab-23: A Cancer-Specific Monoclonal Antibody Against Human Podoplanin.
    Yamada S; Ogasawara S; Kaneko MK; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2017 Apr; 36(2):72-76. PubMed ID: 28387591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LpMab-12 Established by CasMab Technology Specifically Detects Sialylated O-Glycan on Thr52 of Platelet Aggregation-Stimulating Domain of Human Podoplanin.
    Kato Y; Ogasawara S; Oki H; Goichberg P; Honma R; Fujii Y; Kaneko MK
    PLoS One; 2016; 11(3):e0152912. PubMed ID: 27031228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of monoclonal antibody LpMab-3 recognizing sialylated glycopeptide of podoplanin.
    Oki H; Ogasawara S; Kaneko MK; Takagi M; Yamauchi M; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2015 Feb; 34(1):44-50. PubMed ID: 25723283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of Monoclonal Antibody LpMab-10 Recognizing Non-glycosylated PLAG1/2 Domain Including Thr34 of Human Podoplanin.
    Ogasawara S; Oki H; Kaneko MK; Hozumi Y; Liu X; Honma R; Fujii Y; Nakamura T; Goto K; Takagi M; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2015 Oct; 34(5):318-26. PubMed ID: 26492619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor effect of novel anti-podoplanin antibody NZ-12 against malignant pleural mesothelioma in an orthotopic xenograft model.
    Abe S; Kaneko MK; Tsuchihashi Y; Izumi T; Ogasawara S; Okada N; Sato C; Tobiume M; Otsuka K; Miyamoto L; Tsuchiya K; Kawazoe K; Kato Y; Nishioka Y
    Cancer Sci; 2016 Sep; 107(9):1198-205. PubMed ID: 27294401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Humanized and Defucosylated Antibody against Podoplanin (humLpMab-23-f) Exerts Antitumor Activities in Human Lung Cancer and Glioblastoma Xenograft Models.
    Suzuki H; Ohishi T; Kaneko MK; Kato Y
    Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of Monoclonal Antibody LpMab-7 Recognizing Non-PLAG Domain of Podoplanin.
    Oki H; Kaneko MK; Ogasawara S; Tsujimoto Y; Liu X; Sugawara M; Takakubo Y; Takagi M; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2015 Jun; 34(3):174-80. PubMed ID: 26090595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LpMab-19 Recognizes Sialylated O-Glycan on Thr76 of Human Podoplanin.
    Ogasawara S; Kaneko MK; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2016 Oct; 35(5):245-253. PubMed ID: 27564251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cancer-specific monoclonal antibody recognizes the aberrantly glycosylated podoplanin.
    Kato Y; Kaneko MK
    Sci Rep; 2014 Aug; 4():5924. PubMed ID: 25080943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.